Dec 2006: How 'Good' is Your Deal Sheet?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Released on: December 01, 2006. © PharmaVentures Ltd
Episode Information
  • Summary
  • Text
The December commentary discusses the difficulties associated with rating a deal maker according to the record shown on their deal sheet and, in particular, rating a person who has been active in deal making but has never yet successfully concluded a deal. The problem here is that failure is not something one associates with success. One looks at the deal sheet and concludes that this person is inept at negotiating a deal. But is this right? A lot of deals are 'not to be', and good deal makers conclude quality deals but walk away from deals that they know will not work for them or the other party.
A deal sheet is usually a record of all the deals that you have been involved with. Many investment bankers, consultants, and business development and licensing executives keep deal sheets as a record of their successes. In my time I have seen a significant number of deal sheets from people who want to join PharmaVentures. Obviously a long deal sheet of successfully completed transactions is a real asset that defines and differentiates the true ability of the deal maker. It is natural therefore to rate someone's ability on the basis of the number of deals completed. So how should you rate a person who has been active in deal making but has never yet successfully concluded one? The problem with this concept is that failure is not something one associates with success. One looks at the deal sheet and concludes that this person is inept at negotiating a deal. However, those of you who know my views on deal making also know that I am a great fan of the deals that never happen - or dare I say - fail to happen. So my first reaction is not negative but rather curious when I meet someone who honestly and frankly says to me that, although they have been involved in many attempts to do deals, they have never successfully completed one. To me what is important is why they never concluded the deal and, more importantly, when did they terminate discussions? "So how should you rate a person who has been active in deal making but has never yet successfully concluded one? The problem with this concept is that failure is not something one associates with success. One looks at the deal sheet and concludes that this person is inept at negotiating a deal." A lot of deals are 'not to be'. Successful deal making is about concluding a deal with the right partner under terms that are a true win-win for both parties. There are lots of deals signed that turn out to be disasters for both sides. Good deal makers conclude quality deals but walk away from deals that they know will not work for them or the other party. So some people's deal sheets make look impressive, with a long list of concluded deals - but how many of those deals actually turned out to be truly successful? In the end I rate a deal maker by both the ability to win quality deals with good outcomes as well as the ability to walk away early from potential deals that don't make sense. Furthermore, there are lots of deals that never happen because external factors impacted and terminated negotiations - factors such as a company takeover, a change in strategy, a change in management, etc. So, in my view, good deal makers have a strong record of both concluded and non-concluded deals. -Fintan Walton, Chief Executive Officer, PharmaVentures Ltd.
Scroll Up
The whole title
Recent Episodes
Watch recent episodes on PDeals Commentaries
May 2009: Japan on the Move
Recent Episodes
Watch recent episodes on PDeals Commentaries
April 2009: Financing Risk
Recent Episodes
Watch recent episodes on PDeals Commentaries
March 2009: China Remains an Opportunity
Recent Episodes
Watch recent episodes on PDeals Commentaries
January 2009: How to Survive in Tough Economic Times
Recent Episodes
Watch recent episodes on PDeals Commentaries
December 2008: The Rebirth of Regenerative Medicine
Recent Episodes
Watch recent episodes on PDeals Commentaries
November 2008: The Impact of the Financial Crisis on the Biotech and Pharma Industry
Recent Episodes
Watch recent episodes on PDeals Commentaries
October 2008: Biodiversity
Recent Episodes
Watch recent episodes on PDeals Commentaries
September 2008: Will Lehman’s Collapse Affect the Pharmaceutical Industry?
Recent Episodes
Watch recent episodes on PDeals Commentaries
August 2008: US Election will impact new drug development worldwide forever
Recent Episodes
Watch recent episodes on PDeals Commentaries
July 2008: June Gloom
Recent Episodes
Watch recent episodes on PDeals Commentaries
May 2008: The Next Generation PharmaDeals
Recent Episodes
Watch recent episodes on PDeals Commentaries
April 2008: Times They Are A Changing
Recent Episodes
Watch recent episodes on PDeals Commentaries
March 2008: Patent Reform Could Threaten Innovation
Recent Episodes
Watch recent episodes on PDeals Commentaries
Feb 2008: The Sun Rises in Japan
Recent Episodes
Watch recent episodes on PDeals Commentaries
Jan 2008: Encouraging Entrepreneurialism
Recent Episodes
Watch recent episodes on PDeals Commentaries
Dec 2007: Big Pharma and the Young CEO
Recent Episodes
Watch recent episodes on PDeals Commentaries
Nov 2007: Passion and Determination are Success Drivers for Entrepreneurs
Recent Episodes
Watch recent episodes on PDeals Commentaries
Oct 2007: The CEO's Balancing Act
Recent Episodes
Watch recent episodes on PDeals Commentaries
Sep 2007: Communicating Health
Recent Episodes
Watch recent episodes on PDeals Commentaries
July 2007: Europe United?
Recent Episodes
Watch recent episodes on PDeals Commentaries
June 2007: Pricing Drugs
Recent Episodes
Watch recent episodes on PDeals Commentaries
May 2007: Paying Too Much?
Recent Episodes
Watch recent episodes on PDeals Commentaries
April 2007: How Virtual Biotech has Changed the World
Recent Episodes
Watch recent episodes on PDeals Commentaries
March 2007: What's a Good Pipeline?
Recent Episodes
Watch recent episodes on PDeals Commentaries
Feb 2007: Funding Research
Recent Episodes
Watch recent episodes on PDeals Commentaries
Jan 2007: Where Now for Biotech?
Recent Episodes
Watch recent episodes on PDeals Commentaries
Dec 2006: How 'Good' is Your Deal Sheet?
Recent Episodes
Watch recent episodes on PDeals Commentaries
Scroll Down